QuidelOrtho Corporation - SIC # 3840 -

Ticker Exchange SIC # Website Latest Ticker
QDEL Nasdaq 3840 www.quidelortho.com

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for QuidelOrtho Corporation

Rice Hall James Buys QuidelOrtho Stock - Mar 9th, 2026 7:25 am
3 Unprofitable Stocks That Concern Us - Mar 9th, 2026 4:42 am
PacBio, CONMED, Moderna, QuidelOrtho, and Tandem Diabetes Shares Are Falling, What You Need To Know - Mar 6th, 2026 3:24 pm
QuidelOrtho (QDEL): Buy, Sell, or Hold Post Q4 Earnings? - Mar 3rd, 2026 7:21 am
QuidelOrtho Corp Director Purchases 10k Shares as CFO Retires - Mar 1st, 2026 7:38 pm
Why The QuidelOrtho (QDEL) Story Is Shifting As Analysts Rework Growth And Valuation Assumptions - Feb 25th, 2026 7:09 pm
Guardant Health, PacBio, Align Technology, QuidelOrtho, and Omnicell Shares Are Falling, What You Need To Know - Feb 23rd, 2026 10:00 am
1 Russell 2000 Stock to Keep an Eye On and 2 We Brush Off - Feb 22nd, 2026 9:31 pm
Vistance Networks Stock Up 250%. Here's Why a $40 Million Position Signals a Post-Divestiture Bet - Feb 22nd, 2026 2:25 pm
Array Stock Down 25%, But This $17.3 Million Buy Signals Confidence Amid Big Revenue Growth - Feb 22nd, 2026 2:16 pm
Enviri Stock Up 120% as $43 Million Buy Makes It a Top Holding in This Portfolio - Feb 22nd, 2026 2:06 pm
Integer Stock Down 38%, but One Fund Just Bet $40 Million on a Turnaround - Feb 22nd, 2026 1:56 pm
Can QuidelOrtho’s (QDEL) Lifotronic Deal Reshape Its Global Immunoassay Competitiveness Story? - Feb 19th, 2026 2:12 pm
Faster Cardiac Answers with High‑Sensitivity Troponin - Feb 19th, 2026 7:17 am
3 Small-Cap Stocks We Approach with Caution - Feb 18th, 2026 9:33 pm
QuidelOrtho to Present at the 47th Annual Raymond James Institutional Investor Conference - Feb 18th, 2026 2:05 pm
The Top 5 Analyst Questions From QuidelOrtho’s Q4 Earnings Call - Feb 17th, 2026 10:36 pm
QDEL Expands Immunoassay Portfolio Via Lifotronic Supply Agreement - Feb 17th, 2026 9:12 am
QuidelOrtho and Lifotronic agree on global immunoassay portfolio expansion - Feb 16th, 2026 4:59 am
QuidelOrtho Enters Strategic Supply Agreement to Expand Global Immunoassay Portfolio - Feb 15th, 2026 11:00 pm